-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2008.jsp
January 01, 2008 - is not present, (1) Comorbidity is present
CM_RENLFAIL
2002-2008
AHRQ comorbidity measure: Renal
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables.xls
January 01, 2006 - 2006-2009
Note: A single period (.) signifies a small cell count (less than 11); ESRD = end stage renal
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dxsafety-facilitators-guide.pdf
February 04, 2022 - reality-based case describes the diagnostic journey of a 49-year-old patient, Joe Kane, with
end stage renal
-
hcup-us.ahrq.gov/db/nation/kid/KID_2009_Introduction.pdf
January 01, 2009 - measure: Pulmonary circulation disorders
CM_RENLFAIL 2003, 2006,
2009
AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/2006NIS_INTRODUCTION.pdf
November 01, 2015 - comorbidity measure: Pulmonary circulation
disorders
CM_RENLFAIL 2002-2006 AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/reports/2001niscomparisonrpt.jsp
November 01, 2015 - 0.01)
1.01*
6.76 (0.06)
6.85
2.93 (0.11)
3.12
$23,701 (460)
$22,790*
316: Renal
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TjDzC7rzm3WzCDHFC4sJhQ
June 01, 2015 - Effects of ramipril and
rosiglitazone on cardiovascular and renal outcomes in people with
impaired glucose
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/o6pGCffkVCx24mNebJGCXg
January 01, 2013 - refers to the cross-
linking of polyethylene glycol molecules to the interferon
molecule, which delays renal
-
qualityindicators.ahrq.gov/Downloads/Resources/Publications/2012/Appendix_1A_Details_of_literature_review.pdf
January 01, 2012 - patients experienced multi-organ dysfunction with neurological impairment (100%),
moderate-to-severe renal
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/k_QR3hvh2jVSPPLu6Q6m6r
November 13, 2022 - Asselbergs FW, Diercks GF, Hillege HL, et al;
Prevention of Renal and Vascular Endstage Disease
Intervention
-
hcup-us.ahrq.gov/reports/methods/NIS_Comparison_Report_2001.pdf
January 01, 2001 - 134
(3)
114** 0.98
(0.01)
1.01* 6.76
(0.06)
6.85 2.93
(0.11)
3.12 $23,701
(460)
$22,790*
316: Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2010.jsp
January 01, 2010 - is not present, (1) Comorbidity is present
CM_RENLFAIL
2002-2010
AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2009.jsp
January 01, 2009 - is not present, (1) Comorbidity is present
CM_RENLFAIL
2002-2009
AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.jsp
January 01, 2011 - is not present, (1) Comorbidity is present
CM_RENLFAIL
2002-2011
AHRQ comorbidity measure: Renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - refers to the cross-linking of
polyethylene glycol molecules to the interferon molecule, which delays renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
September 01, 2012 - BACKGROUND: Chronic renal failure and haemodialysis treatment is a long-term process;
patients need
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - weight)
Systemic Lupus
Erythematosus Disease
Activity Index
Lupus serology (ANA, dsDNA,
C3, C4)
Renal
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/multichronic/summit-bios.html
November 01, 2021 - former Chair of the Public Policy Committee and a member of the Board of Directors of the Mid-Atlantic Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_2008_INTRODUCTION.pdf
January 01, 2008 - Comorbidity is not present, (1)
Comorbidity is present
CM_RENLFAIL 2002-2008 AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_2007_INTRODUCTION.pdf
January 01, 2007 - Comorbidity is not present, (1)
Comorbidity is present
CM_RENLFAIL 2002-2007 AHRQ comorbidity measure: Renal